Bio-Technology General Euflexxa 1% Sodium Hyaluronate

Maa: Singapore

Kieli: englanti

Lähde: HSA (Health Sciences Authority)

Saatavilla:

FERRING PHARMACEUTICALS PRIVATE LIMITED

luokka:

Class D medical device

Valmistaja:

Bio-Technology General (Israel) Ltd.

Terapeuttinen alue:

Orthopaedics

Käyttöaiheet:

EUFLEXXA is indicated for the treatment of pain caused by osteoarthritis of the knee, hip, temporomandibular, carpometacarpal, shoulder and ankle joints. EUFLEXXA aids in lubrication of the joint, allows for greater mobility and flexibility of the treated joint, and reduces pain in the affected joint.

Tuoteyhteenveto:

Device System Info:[Sterile Medical Device], EUFLEXXA is packed in a single-use, aseptically-filled disposable sterile 2.25 ml syringe (nominal volume) containing either 1 ml or 2 ml of 1% microbial fermentation-derived NaHA in phosphate-buffered saline; Models: Euflexxa 1% Sodium Hyaluronate - 3 x 2ml, Euflexxa 1% Sodium Hyaluronate - 1 x 2ml

Valtuutus päivämäärä:

2017-04-28